Schedule 13G ownership disclosure

BEYONDSPRING INC

Ordinary Shares, par value $0.0001 per share · CUSIP: G10830100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Decheng Capital Management III (Cayman), LLC

    Shares: 1,448,293.00 · Class: 3.5%

  • Decheng Capital China Life Sciences USD Fund III, L.P.

    Shares: 1,448,293.00 · Class: 3.5%

  • Decheng Capital China Life Sciences USD Fund II, L.P.

    Shares: 1,617,409.00 · Class: 3.9%

  • Decheng Capital Management II (Cayman), LLC

    Shares: 1,617,409.00 · Class: 3.9%

  • Decheng Capital Global Healthcare Fund (Master), LP

    Shares: 735,000.00 · Class: 1.8%

  • Decheng Capital Global Healthcare GP, LLC

    Shares: 735,000.00 · Class: 1.8%

  • Xiangmin Cui

    Shares: 3,800,702.00 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001747821-26-000004
Form type
SCHEDULE 13G/A
Filer
BeyondSpring Inc.
CIK
CIK 1677940
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub